Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,775 public trials 502 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT06322342

Conditions: Acoustic Neuroma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +61 more
Locations: Yale New Haven Hospital New Haven, Connecticut, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Brigham & Women's Hospital Boston, Massachusetts, United States

University of Missouri Columbia, Missouri, United States

View Trial Details

Completed

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma

NCT07305285

Conditions: Acoustic Neuroma, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Completed

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

NCT03406208

Conditions: Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +29 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Study of GC101 TIL in Advanced Melanoma (BZ)

NCT06120712

Conditions: Adverse Drug Event, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +15 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

NCT04889118

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations: Beijing Cancer Hospital (0601) Beijing, Beijing Municipality, China

Fujian Provincial Cancer Hospital ( Site 0612) Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center (0602) Guangzhou, Guangdong, China

Henan Cancer Hospital ( Site 0610) Zhengzhou, Henan, China

View Trial Details

Completed

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

NCT01319565

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

NCT01005745

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Using MC1R Genotype to Impact Melanoma Risk Behavior

NCT03509467

Conditions: Basal Cell Cancer, Basal Cell Carcinoma, Carcinoma, +21 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Ponce School of Medicine Ponce, Puerto Rico

View Trial Details

Completed

Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

NCT01701674

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

NCT07291752

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations: Not specified

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions